<DOC>
	<DOC>NCT01016470</DOC>
	<brief_summary>The purpose of the study is to evaluate whether Viusid/Alzer Nutritional supplements, could improve the progression disease, in patients with Parkinson's Disease (PD).</brief_summary>
	<brief_title>Efficacy of Nutritional Supplement VIUSID/ALZER in Patients With Parkinson`s Disease</brief_title>
	<detailed_description>Periodical measures of the clinical features with UPDRS will be done at the beginning, each three months until two years. Each group will be compare to evaluate.</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>Patients with clinical of PD, with the criteria of Brain Bank of London with early stage. Informed consent. Presence of another disease not well controlled. Patient with atypical features. Patient with advanced Parkinson`s disease.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2012</verification_date>
</DOC>